PMC:1283364 / 49687-49858
Annnotations
craft-sa-dev
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T10815 | 0-171 | sentence | denotes | Notably, pharmaceutical γ-secretase inhibitors published to date show less strict regulation of Aβ production following chronic administration than we have attained here. |
| T10816 | 1-8 | RB | denotes | Notably |
| T10817 | 66-70 | VBP | denotes | show |
| T10818 | 8-10 | , | denotes | , |
| T10819 | 10-24 | JJ | denotes | pharmaceutical |
| T10820 | 37-47 | NNS | denotes | inhibitors |
| T10821 | 25-26 | SYM | denotes | γ |
| T10822 | 27-36 | NN | denotes | secretase |
| T10823 | 26-27 | HYPH | denotes | - |
| T10824 | 48-57 | VBN | denotes | published |
| T10825 | 58-60 | IN | denotes | to |
| T10826 | 61-65 | NN | denotes | date |
| T10827 | 71-75 | RBR | denotes | less |
| T10828 | 76-82 | JJ | denotes | strict |
| T10829 | 83-93 | NN | denotes | regulation |
| T10830 | 94-96 | IN | denotes | of |
| T10831 | 97-99 | NN | denotes | Aβ |
| T10832 | 100-110 | NN | denotes | production |
| T10833 | 111-120 | VBG | denotes | following |
| T10834 | 121-128 | JJ | denotes | chronic |
| T10835 | 129-143 | NN | denotes | administration |
| T10836 | 144-148 | IN | denotes | than |
| T10837 | 157-165 | VBN | denotes | attained |
| T10838 | 149-151 | PRP | denotes | we |
| T10839 | 152-156 | VBP | denotes | have |
| T10840 | 166-170 | RB | denotes | here |
| T10841 | 170-171 | . | denotes | . |
| R7243 | T10816 | T10817 | advmod | Notably,show |
| R7244 | T10818 | T10817 | punct | ", ",show |
| R7245 | T10819 | T10820 | amod | pharmaceutical,inhibitors |
| R7246 | T10820 | T10817 | nsubj | inhibitors,show |
| R7247 | T10821 | T10822 | punct | γ,secretase |
| R7248 | T10822 | T10820 | compound | secretase,inhibitors |
| R7249 | T10823 | T10822 | punct | -,secretase |
| R7250 | T10824 | T10820 | acl | published,inhibitors |
| R7251 | T10825 | T10824 | prep | to,published |
| R7252 | T10826 | T10825 | pobj | date,to |
| R7253 | T10827 | T10828 | advmod | less,strict |
| R7254 | T10828 | T10829 | amod | strict,regulation |
| R7255 | T10829 | T10817 | dobj | regulation,show |
| R7256 | T10830 | T10829 | prep | of,regulation |
| R7257 | T10831 | T10832 | compound | Aβ,production |
| R7258 | T10832 | T10830 | pobj | production,of |
| R7259 | T10833 | T10829 | prep | following,regulation |
| R7260 | T10834 | T10835 | amod | chronic,administration |
| R7261 | T10835 | T10833 | pobj | administration,following |
| R7262 | T10836 | T10837 | mark | than,attained |
| R7263 | T10837 | T10829 | advcl | attained,regulation |
| R7264 | T10838 | T10837 | nsubj | we,attained |
| R7265 | T10839 | T10837 | aux | have,attained |
| R7266 | T10840 | T10837 | advmod | here,attained |
| R7267 | T10841 | T10817 | punct | .,show |
craft-ca-core-ex-dev
Below, discontinuous spans are shown in the bag model. You can change it to the chain model.
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T10238 | 10-24 | CHEBI_EXT:52217 | denotes | pharmaceutical |
| T10239 | 25-36 | GO:0070765 | denotes | γ-secretase |
| T10240 | 37-47 | CHEBI_EXT:35222 | denotes | inhibitors |
| T10241 | 83-110 | GO:1902003 | denotes | regulation of Aβ production |
| T10242 | 97-99 | CHEBI_PR_EXT:amyloid_beta | denotes | Aβ |
craft-ca-core-dev
Below, discontinuous spans are shown in the bag model. You can change it to the chain model.
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T9965 | 10-24 | CHEBI:52217 | denotes | pharmaceutical |
| T9966 | 25-36 | GO:0070765 | denotes | γ-secretase |
| T9967 | 37-47 | CHEBI:35222 | denotes | inhibitors |
| T9968 | 83-110 | GO:1902003 | denotes | regulation of Aβ production |